Bristol-Myers NASH drug reduces liver fat in midstage study
The Bristol drug also led to improvements in cholesterol and triglycerides, researchers reported
Author
Eating tree nuts may cut risk that colon cancer will return: Study
All of the patients in the study had received surgery and chemotherapy to treat their colon cancers
First-in-class innovation a key strategy for pharma companies in a harsh market environment: GBI…
The report also mentions that a product entering into clinical development has a 72 per cent likelihood of failing to reach the…
Haematological cancers pharma pipeline one of the strongest within oncology: GBI Research
The haematological cancers pipeline, which covers leukaemia, lymphoma and myeloma, is the largest within the oncology therapy area…
Global immunology market to surpass $75 bn by 2022 despite patent expirations
According to GBI research, the large immunology pipeline consists of 2,054 products in active development, almost 100 of which are…
Growth hormone deficiency market to grow steadily, surpassing $2 bn by 2026
According to a report by GlobalData, major drivers of this growth include the launch of long-acting growth hormones, improved…
Taking the green path
Express Pharma analyses efforts to make the formulation
development and drug discovery process more sustainable and…
Leading the pack
Kanish Malik, President, Operations, Glenmark Pharmaceuticals and SV Veerramani, Founder and Chairman, Fourrts India, explain the…
Thinking beyond medicines and products
Vivek P Adhia, Strategy Head – Climate, WRI India, Tanvi Bongale, Sr Project Associate, Climate, WRI India, Shruti Karkhedkar, Air…
The monster in your laboratory
Sekhar Surabhi, CEO and President at Caliber Technologies, insists on paperless automation and recommends a shift to a completely…